Navigation Links
The superior steroids

Researchers say, that a steroid nasal spray may relieve seasonal allergy symptoms better than an oral antihistamine. Dr. Robert Naclerio and colleagues from University of Chicago,compared the effectiveness of fluticasone(Flonase)//,a corticosteroid nasal spray, with loratadine(Claritin),a nonsedating antihistamine, for treating ragweed allergy on an as-needed basis..

Participants who used the inhaled steroid experienced significantly fewer allergy symptoms and reported less impact on their quality of life than those who took the antihistamine. During the four-week study, 88 participants took either the steroid nasal spray or antihistamine on an as-needed basis. They kept a daily diary of their allergy symptoms and completed a quality-of-life questionnaire.

Researchers looked for chemical evidence of allergic reaction, such as eosinophils, in participants' blood. Eosinophils are white blood cells involved in defending the body from allergens. For best results, experts generally recommend that you use either an inhaled steroid or an antihistamine on a continuous, long-term basis.

But the researchers point out that most people tend to wait until symptoms appear before taking allergy medications. This may be one reason for the superiority of the steroid nasal spray in the study. Unlike inhaled corticosteroids, antihistamines like Claritin are not very effective in blocking the allergic response once it has begun.


'"/>




Page: 1

Related medicine news :

1. ATG useful in transplant patients as substitute for steroids
2. Tentative inhaled steroids is worse for lung patients
3. Corticosteroids Safe for Bones
4. Corticosteroids Safe for Bones
5. Inhaled Corticosteroids Found To Have No Significant Effect On COPD
6. The Effectiveness Of Inhaled Corticosteroids Studied
7. The Effectiveness Of Inhaled Corticosteroids Studied
8. Routine use of steroids can lead to death for patients with brain injury
9. Adrenal Suppression not predicted by inhaled corticosteroids
10. Inhaled Corticosteroids Reduce Death in Patients with COPD
11. Inhaled Corticosteroids may Reduce Lung Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical Therapy ... the preferred physical therapy provider for Derby City CrossFit, effective immediately. , In ... as quickly and effectively as possible, ProRehab’s sports physical therapists will work with ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... Liberty attempts to compare student test score performance for the 2015-16 school year ... the state’s voucher programs. Though it highlights important patterns in student test score ...
(Date:4/25/2017)... ... 2017 , ... As pharmaceutical companies are held to increasingly ... innovation in drug formulation and manufacturing. CoreRx offers its clients more than ... support of their development and manufacturing goals. , The company was created ...
(Date:4/25/2017)... ... , ... Saad B. Chaudhary, MD is committed to providing the highest quality of spine care ... on preventative care with all my patients to alleviate possible future issues. I am pleased ... contact my office and my trained staff will assist you in any way possible.” , ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® , a ... UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event ... the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
(Date:4/19/2017)...  IRIDEX Corporation (Nasdaq: IRIX ) today ... first quarter 2017 after the close of trading on ... host a corresponding conference call beginning at 2:30 p.m. ... in listening to the conference call may do so ... 326-3030 for international callers, using conference ID: 92158987.  A ...
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
Breaking Medicine Technology: